Covered recipient · General Payments record
KENDYL R ZEISLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$437.84
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $437.84 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $189.37 | 20 |
| Novo Nordisk AS | $81.30 | 5 |
| Acerta Pharma LLC | $32.04 | 2 |
| Amgen Inc. | $20.68 | 1 |
| Ardelyx, Inc. | $19.76 | 1 |
| SANOFI PASTEUR INC. | $19.63 | 1 |
| Merck Sharp & Dohme Corporation | $16.24 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.35 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.01 | 1 |
| Exact Sciences Corporation | $14.51 | 1 |
| Lilly USA, LLC | $13.95 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $437.84 | 35 |
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.99 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458938 | CMS |
| ABBVIE INC. | $8.13 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458940 | CMS |
| ABBVIE INC. | $16.11 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458942 | CMS |
| ABBVIE INC. | $5.68 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458944 | CMS |
| ABBVIE INC. | $6.63 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458946 | CMS |
| ABBVIE INC. | $6.52 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458948 | CMS |
| ABBVIE INC. | $7.57 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458950 | CMS |
| ABBVIE INC. | $16.79 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458952 | CMS |
| ABBVIE INC. | $6.50 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458954 | CMS |
| ABBVIE INC. | $16.13 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458956 | CMS |
| ABBVIE INC. | $7.25 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458958 | CMS |
| ABBVIE INC. | $7.56 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458960 | CMS |
| ABBVIE INC. | $7.34 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458962 | CMS |
| ABBVIE INC. | $7.10 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458964 | CMS |
| ABBVIE INC. | $6.60 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458966 | CMS |
| ABBVIE INC. | $16.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458968 | CMS |
| ABBVIE INC. | $5.88 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458970 | CMS |
| ABBVIE INC. | $21.81 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458972 | CMS |
| ABBVIE INC. | $5.62 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458974 | CMS |
| ABBVIE INC. | $7.29 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108458976 | CMS |
| Amgen Inc. | $20.68 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422104 | CMS |
| Ardelyx, Inc. | $19.76 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146751408 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.39 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105644128 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.65 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105575690 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.01 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086297158 | CMS |
| Exact Sciences Corporation | $14.51 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114549003 | CMS |
| Lilly USA, LLC | $13.95 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135748624 | CMS |
| Merck Sharp & Dohme LLC | $16.24 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141884547 | CMS |
| Novo Nordisk Inc | $16.51 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100656465 | CMS |
| Novo Nordisk Inc | $13.11 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100321386 | CMS |
| Novo Nordisk Inc | $16.25 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100538946 | CMS |
| Novo Nordisk Inc | $17.54 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100347026 | CMS |
| Novo Nordisk Inc | $17.89 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100640160 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.35 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119220465 | CMS |
| SANOFI PASTEUR INC. | $19.63 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128758350 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.